Free Trial

City of London (CTY) Competitors

City of London logo
GBX 550 +5.00 (+0.92%)
As of 12:27 PM Eastern

CTY vs. DPLM, IGG, DPH, HWDN, and GNS

Should you buy City of London stock or one of its competitors? MarketBeat compares City of London with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with City of London include Diploma (DPLM), IG Group (IGG), Dechra Pharmaceuticals (DPH), Howden Joinery Group (HWDN), and Genus (GNS). These companies are all part of the "personal services" industry.

How does City of London compare to Diploma?

Diploma (LON:DPLM) and City of London (LON:CTY) are both mid-cap personal services companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

City of London has a net margin of 97.40% compared to Diploma's net margin of 8.99%. City of London's return on equity of 22.92% beat Diploma's return on equity.

Company Net Margins Return on Equity Return on Assets
Diploma8.99% 14.17% 8.32%
City of London 97.40%22.92%4.00%

68.2% of Diploma shares are owned by institutional investors. Comparatively, 8.7% of City of London shares are owned by institutional investors. 1.1% of Diploma shares are owned by insiders. Comparatively, 0.1% of City of London shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

City of London has lower revenue, but higher earnings than Diploma. City of London is trading at a lower price-to-earnings ratio than Diploma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Diploma£1.52B6.03£115.40M£137.3049.93
City of London£568.96M4.93£294.08M£113.994.82

Diploma has a beta of 0.917, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, City of London has a beta of 0.8609003, suggesting that its stock price is 14% less volatile than the broader market.

Diploma currently has a consensus target price of GBX 6,251.25, suggesting a potential downside of 8.81%. Given Diploma's stronger consensus rating and higher possible upside, analysts clearly believe Diploma is more favorable than City of London.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Diploma
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.63
City of London
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Diploma pays an annual dividend of GBX 60.20 per share and has a dividend yield of 0.9%. City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.9%. Diploma pays out 43.8% of its earnings in the form of a dividend. City of London pays out 18.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. City of London is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, City of London had 2 more articles in the media than Diploma. MarketBeat recorded 3 mentions for City of London and 1 mentions for Diploma. City of London's average media sentiment score of 0.89 beat Diploma's score of 0.00 indicating that City of London is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Diploma
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
City of London
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Diploma beats City of London on 11 of the 18 factors compared between the two stocks.

How does City of London compare to IG Group?

City of London (LON:CTY) and IG Group (LON:IGG) are both mid-cap financial services companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.

In the previous week, City of London had 2 more articles in the media than IG Group. MarketBeat recorded 3 mentions for City of London and 1 mentions for IG Group. City of London's average media sentiment score of 0.89 beat IG Group's score of 0.00 indicating that City of London is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
City of London
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IG Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

City of London has a beta of 0.8609003, suggesting that its share price is 14% less volatile than the broader market. Comparatively, IG Group has a beta of 0.487, suggesting that its share price is 51% less volatile than the broader market.

City of London has a net margin of 97.40% compared to IG Group's net margin of 35.26%. City of London's return on equity of 22.92% beat IG Group's return on equity.

Company Net Margins Return on Equity Return on Assets
City of London97.40% 22.92% 4.00%
IG Group 35.26%20.91%10.37%

City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.9%. IG Group pays an annual dividend of GBX 46.50 per share and has a dividend yield of 3.0%. City of London pays out 18.8% of its earnings in the form of a dividend. IG Group pays out 44.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. City of London is clearly the better dividend stock, given its higher yield and lower payout ratio.

IG Group has a consensus target price of GBX 1,302, suggesting a potential downside of 15.34%. Given IG Group's stronger consensus rating and higher probable upside, analysts plainly believe IG Group is more favorable than City of London.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
City of London
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
IG Group
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

8.7% of City of London shares are owned by institutional investors. Comparatively, 74.0% of IG Group shares are owned by institutional investors. 0.1% of City of London shares are owned by company insiders. Comparatively, 1.2% of IG Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

IG Group has higher revenue and earnings than City of London. City of London is trading at a lower price-to-earnings ratio than IG Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
City of London£568.96M4.93£294.08M£113.994.82
IG Group£949.10M5.36£533.35M£105.1014.63

Summary

IG Group beats City of London on 10 of the 18 factors compared between the two stocks.

How does City of London compare to Dechra Pharmaceuticals?

Dechra Pharmaceuticals (LON:DPH) and City of London (LON:CTY) are both mid-cap personal services companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

Dechra Pharmaceuticals has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, City of London has a beta of 0.8609003, suggesting that its stock price is 14% less volatile than the broader market.

City of London has a net margin of 97.40% compared to Dechra Pharmaceuticals' net margin of -3.66%. City of London's return on equity of 22.92% beat Dechra Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Dechra Pharmaceuticals-3.66% -3.92% 0.75%
City of London 97.40%22.92%4.00%

105.5% of Dechra Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.7% of City of London shares are owned by institutional investors. 9.3% of Dechra Pharmaceuticals shares are owned by company insiders. Comparatively, 0.1% of City of London shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

City of London has lower revenue, but higher earnings than Dechra Pharmaceuticals. Dechra Pharmaceuticals is trading at a lower price-to-earnings ratio than City of London, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dechra Pharmaceuticals£761.50M0.00-£27.90M-£0.25N/A
City of London£568.96M4.93£294.08M£113.994.82

Dechra Pharmaceuticals pays an annual dividend of GBX 45 per share. City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.9%. Dechra Pharmaceuticals pays out -18,000.0% of its earnings in the form of a dividend. City of London pays out 18.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, City of London had 3 more articles in the media than Dechra Pharmaceuticals. MarketBeat recorded 3 mentions for City of London and 0 mentions for Dechra Pharmaceuticals. City of London's average media sentiment score of 0.89 beat Dechra Pharmaceuticals' score of 0.00 indicating that City of London is being referred to more favorably in the news media.

Company Overall Sentiment
Dechra Pharmaceuticals Neutral
City of London Positive

Summary

City of London beats Dechra Pharmaceuticals on 10 of the 14 factors compared between the two stocks.

How does City of London compare to Howden Joinery Group?

City of London (LON:CTY) and Howden Joinery Group (LON:HWDN) are both mid-cap personal services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

8.7% of City of London shares are held by institutional investors. Comparatively, 67.4% of Howden Joinery Group shares are held by institutional investors. 0.1% of City of London shares are held by insiders. Comparatively, 0.9% of Howden Joinery Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

City of London has a beta of 0.8609003, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Howden Joinery Group has a beta of 1.298, suggesting that its share price is 30% more volatile than the broader market.

In the previous week, City of London had 3 more articles in the media than Howden Joinery Group. MarketBeat recorded 3 mentions for City of London and 0 mentions for Howden Joinery Group. City of London's average media sentiment score of 0.89 beat Howden Joinery Group's score of 0.00 indicating that City of London is being referred to more favorably in the media.

Company Overall Sentiment
City of London Positive
Howden Joinery Group Neutral

Howden Joinery Group has a consensus price target of GBX 924, suggesting a potential upside of 26.02%. Given Howden Joinery Group's stronger consensus rating and higher possible upside, analysts clearly believe Howden Joinery Group is more favorable than City of London.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
City of London
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Howden Joinery Group
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20

City of London has a net margin of 97.40% compared to Howden Joinery Group's net margin of 11.07%. Howden Joinery Group's return on equity of 23.58% beat City of London's return on equity.

Company Net Margins Return on Equity Return on Assets
City of London97.40% 22.92% 4.00%
Howden Joinery Group 11.07%23.58%10.70%

City of London has higher earnings, but lower revenue than Howden Joinery Group. City of London is trading at a lower price-to-earnings ratio than Howden Joinery Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
City of London£568.96M4.93£294.08M£113.994.82
Howden Joinery Group£2.42B1.64£253.42M£49.0014.96

City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.9%. Howden Joinery Group pays an annual dividend of GBX 21.30 per share and has a dividend yield of 2.9%. City of London pays out 18.8% of its earnings in the form of a dividend. Howden Joinery Group pays out 43.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. City of London is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Howden Joinery Group beats City of London on 10 of the 18 factors compared between the two stocks.

How does City of London compare to Genus?

City of London (LON:CTY) and Genus (LON:GNS) are both personal services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

8.7% of City of London shares are owned by institutional investors. Comparatively, 53.1% of Genus shares are owned by institutional investors. 0.1% of City of London shares are owned by company insiders. Comparatively, 0.7% of Genus shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

City of London has a beta of 0.8609003, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Genus has a beta of 0.895, suggesting that its share price is 11% less volatile than the broader market.

In the previous week, Genus had 3 more articles in the media than City of London. MarketBeat recorded 6 mentions for Genus and 3 mentions for City of London. City of London's average media sentiment score of 0.89 beat Genus' score of 0.21 indicating that City of London is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
City of London
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Genus
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Genus has a consensus price target of GBX 3,216.67, suggesting a potential upside of 38.03%. Given Genus' stronger consensus rating and higher probable upside, analysts plainly believe Genus is more favorable than City of London.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
City of London
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Genus
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

City of London has a net margin of 97.40% compared to Genus' net margin of 7.07%. City of London's return on equity of 22.92% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
City of London97.40% 22.92% 4.00%
Genus 7.07%9.70%3.31%

City of London has higher earnings, but lower revenue than Genus. City of London is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
City of London£568.96M4.93£294.08M£113.994.82
Genus£672M2.30£7.87M£71.0032.82

City of London pays an annual dividend of GBX 21.45 per share and has a dividend yield of 3.9%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.4%. City of London pays out 18.8% of its earnings in the form of a dividend. Genus pays out 45.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. City of London is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

City of London and Genus tied by winning 9 of the 18 factors compared between the two stocks.

Get City of London News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTY vs. The Competition

MetricCity of LondonAsset Management IndustryFinancial SectorLON Exchange
Market Cap£2.80B£2.38B£5.76B£2.79B
Dividend Yield4.14%5.99%5.27%6.09%
P/E Ratio4.8225.2215.79366.15
Price / Sales4.931,964.78933.8888,429.84
Price / CashN/A60.1790.3227.89
Price / Book1.311.354.407.74
Net Income£294.08M£265.53M£1.15B£5.89B
7 Day Performance-0.17%-0.09%0.41%0.82%
1 Month Performance-4.35%2.43%2.25%2.78%
1 Year Performance17.40%13.46%21.92%87.90%

City of London Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTY
City of London
N/AGBX 550
+0.9%
N/A+15.6%£2.80B£568.96M4.82N/A
DPLM
Diploma
0.9497 of 5 stars
GBX 7,035
-2.6%
GBX 6,251.25
-11.1%
+57.2%£9.43B£1.52B51.243,500
IGG
IG Group
1.0319 of 5 stars
GBX 1,535.50
-1.0%
GBX 1,302
-15.2%
+40.0%£5.08B£949.10M14.612,754
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50MN/A2,457
HWDN
Howden Joinery Group
N/AGBX 793.07
-0.4%
GBX 924
+16.5%
-12.4%£4.28B£2.42B16.1912,000

Related Companies and Tools


This page (LON:CTY) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners